Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptance of Influenza and Pneumococcal Vaccinations in COPD Patients
TCTR20210319008Recruiting
- Sponsor
- Thammasat University
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of influenza vaccine in influenza and pneumococcal disease, sponsored by Thammasat University. Primary endpoints: Vaccination acceptance rate and Factors associated with vaccination acceptance. Started Jun 2020; status: recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenzapneumococcal disease
Beyond the preview
Go deeper on TCTR20210319008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210319008.